The use of steroids to prevent cutaneous reactions to benznidazole in patients with Chagas disease

Pathogens and Global Health

Volumn 107, Issue 3, 2013, Pages 157-160

  Górgolas, Miguel ^a   Robles, Ignacio ^a   Cabello, Alfonso ^a   Pérez Tanoira, Ramón ^a   Peremarch, Concepción Pérez Jorge ^a   Fernández Roblas, Ricardo ^a   Williams, Frances ^a   Manuel Ramos Rincón, José ^b  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

Author keywords

Benznidazole; Chagas disease; Steroids; Trypanosoma cruzi

Indexed keywords

BENZNIDAZOLE; METHYLPREDNISOLONE;

ADULT; ARTICLE; CHAGAS DISEASE; CLINICAL ARTICLE; DRUG DOSE ESCALATION; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG TOLERANCE; DRUG WITHDRAWAL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FEVER; HUMAN; HYPERSENSITIVITY; IMMUNOFLUORESCENCE TEST; MALE; POLYMERASE CHAIN REACTION; RASH;

ADOLESCENT; ADULT; ANTI-INFLAMMATORY AGENTS; CHAGAS DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; NITROIMIDAZOLES; SKIN DISEASES; STEROIDS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84877949166     PISSN: 20477724     EISSN: 20477732     Source Type: Journal    
DOI: 10.1179/2047773213Y.0000000081     Document Type: Article

References (17)

1. Caryn Bern MD. Antitrypanosomal therapy for chronic Chagas' disease. N Engl J Med. 2011;364:2527-34.
2. Hasslocher-Moreno AM, do Brasil PE, de Sousa AS, Xavier SS, Chambela MC, Sperandio da Silva GM. Safety of benznidazole use in the treatment of chronic Chagas' disease. J Antimicrob Chemother. 2012;67:1261-6.
3. Carrilero B, Murcia L, Martínez-Lage L, Segovia M. Side effects of benznidazole treatment in a cohort of patients with Chagas disease in non-endemic country. Rev Esp Quimioter. 2011;24:123-6.
4. Pinazo MJ, Muñoz J, Posada E, López-Chejade P, Gállego M, Ayala E, et al. Tolerance of benznidazole in treatment of Chagas' disease in adults. Antimicrob Agents Chemother. 2010;54:4896-9.
5. Pérez-Ayala A, Pérez-Molina JA, Norman F, Navarro M, Monge-Maillo B, Díaz-Menéndez M, et al. Chagas disease in Latin American migrants: a Spanish challenge. Clin Microbiol Infect. 2011;17:1108-13.
6. Viotti R, Vigiliano C. Side effects of benznidazole as treatment in chronic Chagas disease: fears and realities. Expert Rev Anti Infect Ther. 2009;7:157-63.
7. Sosa-Estani S, Armenti A. Treatment of Chagas disease with benznidazole and thiotic acid. Medicina (B Aires). 2004;64:1-6.
8. Pérez-Molina JA, Pérez-Ayala A, Moreno S, Fernández- González MC, Zamora J, López-Velez R. Use of benznidazole to treat chronic Chagas' disease: a systematic review with a meta-analysis. J Antimicrob Chemother. 2009;64:1139-47.
9. Lerch M, Keller M, Britschgi M, Kanny G, Tache V, Schmid DA, et al. Cross-reactivity patterns of T cells specific for iodinated contrast media. J Allergy Clin Immunol. 2007;119:1529-36.
10. Demoly P, Hillarire-Buys D. Classification and epidemiology of hypersensitivity drug reactions. Immunol Allergy Clin North Am. 2004;24(3):345-56.
11. Joerger M. Prevention and handling of acute allergic and infusion reactions in oncology. Ann Oncol. 2012;23(Suppl. 10):313-9.
12. O'Connor N, Borley A. Prospective audit of the effectiveness of hydrocortisone premedication on drug delivery reactions following amphotericin B lipid complex. Curr Med Res Opin. 2009;25:749-54.
13. Newmark JL, Mehra A, Kumar Singla A. Radiocontrast media allergic reactions and interventional pain practice - a review. Pain Physician. 2012;15:E665-75.
14. Gonzales I, García HH. Current status and future perspectives on the medical treatment of neurocysticercosis. Pathog Glob Health. 2012;106:305-9.
15. Rodríguez-Guardado A, Rodruiguez M, Pérez F, Carbada V, Carton J. Prevención de las reacciones adversas asociadas al benznidazol mediante el uso combinado de dosis escalonadas y dexclorfeniramina. In: VII taller sobre la enferemdad de Chagas importada. Barcelona 5 marzo 2012.
16. Murcia L, Carrilero B, Muñoz MJ, Iborra MA, Segovia M. Usefulness of PCR for monitoring benznidazole response in patients with chronic Chagas' disease: a prospective study in a non-disease-endemic country. J Antimicrob Chemother. 2010;65:1759-64.
17. Pinazo MJ, Espinosa G, Gállego M, López-Chejade PL, Urbina JA, Gascón J. Successful treatment with posaconazole of a patient with chronic Chagas disease and systemic lupus erythematosus. Am J Trop Med. 2010;82:583-7.